(S)-emopamil for the treatment of migraine

Details (S)-emopamil for the treatment of migraine (S)-emopamil for the treatment of migraine

1989-07-06

1990-04-03

Friedman, Stanley J.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Ester doai

A61K 31275

Patent

active

049141252

ABSTRACT:
The use of (S)-emopamil and the salts thereof for the treatment of migraine is described.

REFERENCES:
European Journal of Pharmacology, D. De Wied, vol. 106, 1984, 215, (1985).
Drugs, vol. 31, 149 (1986) Focus on Betaxolol and Tioconazole, D. S. Houston and P. M. Vanhoutte.
Annual Reports in Medicinal Chemistry, vol. 22, Denis M. Bailey, pp. 41-50.
Drugs of Today, vol. 24, No. 2, Feb. 1988, Greenberg et al.
Drugs, Focus on Bezafibrate and Sulbactam/Ampicillin, Jun. 1987, vol. 33, No. 6 (pp. 531-635).
The Journal of the American Medical Association, Nov. 11, 1983, Preliminary Communication, Capt. Glen D. Solomon et al.
Neurology, Official Journal of the American Academy of Neurology, Jul. 1984, vol. 34, No. 7, p. 973 (1984).

Affiliated with

Also associated with

Rating

(S)-emopamil for the treatment of migraine does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with (S)-emopamil for the treatment of migraine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and (S)-emopamil for the treatment of migraine will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1357897